German start-ups need dedicated help, says industry
This article was originally published in Clinica
The German medtech industry is stressing that new companies need special treatment to help them become established in the market. “There are high numbers of start-ups in the innovative industry branches of medical and optical technology,” said Spectaris industry association chief Sven Behrens. “We need to support these companies with our expertise.” Assistance with questions from how to secure finance to managing export trade, coping with environmental regulations, arranging trade fair participation, R&D needs and medical technology approvals are among those areas where industry associations like Berlin-based Spectaris can lend support.
You may also be interested in...
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.
As the UK enters the final week of its 47-year membership of the EU, UK medtech industry and commentators look ahead to the routes beyond Brexit for the UK, and a likely intense and often rocky 11 months of trade deal negotiations with EU and global partners. This article is part one of two.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.